Both in Pharmaceuticals
Arvinas vs Phathom Pharmaceuticals
Over the past year ARVN returned −20.2% and PHAT returned −53.2%; their daily moves had a correlation of 0.27.
ARVN −20.2% PHAT −53.2%Growth of $1, one year, split-adjusted
| Metric | ARVN | PHAT |
|---|---|---|
| Price | $7.58 | $6.34 |
| Market cap | $495.6M | $512.9M |
| Today | +1.75% | +5.84% |
| 1 month | +1.1% | −13.9% |
| 6 months | −22.8% | −46.2% |
| Year to date | −36.1% | −61.8% |
| 1 year | −21.5% | −54.1% |
| Revenue growth (YoY) | +1014.7% | +88.0% |
| Gross margin | 96.4% | 79.7% |
| Net margin | 67.8% | −23.7% |
| P/E (TTM) | 53.3× | — |
| Price / sales | 1.6× | 2.1× |
| Net cash | $567.6M | $16.5M |
| Dividend yield | — | — |
| Volatility (60d) | 48.4% | 70.6% |
| Short % of float | 10.2% | 17.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).